Epitalon and the pineal gland — Highlander Peptide

Melatonin synthesis in rat pineal cells

The pineal gland's connection with Epitalon starts well before the telomere headlines. In the rat pinealocyte experiment published in 2012, AEDG stimulated AANAT and pCREB and raised melatonin in the culture medium. AANAT helps set the pace of melatonin production; pCREB participates in the regulation of gene expression. Adding norepinephrine potentiated the response. These were cultured Wistar rat cells.

I like the experimental specificity: an enzyme, a regulatory protein and an output measured in the same setting. The question of improved human sleep remains open. A culture measurement cannot reveal how often someone wakes, how rested they feel or whether a circadian disturbance improves. Calling Epitalon a pineal bioregulator describes the research proposal; a controlled clinical outcome would give that proposal much more substance.

Epitalon, Epithalon and Epithalamin

This guide cannot prescribe; Promise Peptides (mypromise.com) currently prescribes NAD+ via telehealth with U.S.-licensed clinicians. Each request receives a provider's review and decision; not everyone qualifies. Access is limited to U.S. patients; treatment options differ across states and medications; compounded medicines have no FDA approval.

Epitalon is the synthetic tetrapeptide H-Ala-Glu-Asp-Gly-OH — four amino acids: alanine, glutamic acid, aspartic acid, and glycine. It is also called Epithalon, Epithalone, or the AEDG peptide. Its structural derivation traces to epithalamin, a polypeptide extract of the bovine pineal gland; Epitalon was synthesized as a defined, reproducible molecule from the amino-acid composition of that extract. These two must not be conflated: epithalamin (the extract) and synthetic Epitalon (the tetrapeptide) are chemically distinct. Epitalon remains sold as research-labelled material. Its prescription route is separate from drug approval: it has no FDA, EMA or MHRA drug approval ^[1].

Telomeres in normal and cancer cells

The 2003 human fetal-fibroblast study reported hTERT expression, telomerase activity and telomere elongation in cultures that initially lacked telomerase activity. Telomeres are the repetitive DNA caps at chromosome ends; telomerase can add to them.

An external group replicated and extended the cell-line result in 2025. Normal human cells lengthened telomeres through hTERT upregulation and telomerase activation. Breast-cancer cell lines relied predominantly on Alternative Lengthening of Telomeres, or ALT, a different maintenance route. I welcome the replication, and the cancer-cell result makes any simple celebration of telomere extension difficult. Both findings come from cells in culture. The implications for cancer risk in a living person remain unresolved.

The female SHR mouse experiment

In the female Swiss-derived SHR mouse study, maximum lifespan increased 12.3%, leukemia incidence fell sixfold and chromosome aberrations in bone marrow were lower. Mean lifespan did not differ significantly from controls, and total tumor incidence was unchanged.

The unchanged mean deserves to travel with the maximum. I give neither number permission to stand in for the other. This was a lifespan and spontaneous-tumor study in a particular mouse population. Other rodent cancer experiments discussed in the Epitalon review used narrow induced or transgenic models, which leave the broader human safety question unsettled.

Epithalamin in the human cohort

The observational study of 266 elderly people followed participants for 6-8 years. Epithalamin alone was associated with a 1.6-1.8-fold mortality decrease versus untreated controls; combined thymalin and Epithalamin was associated with a 4.1-fold decrease. The study lacked randomization and a placebo arm.

Its title makes a substantial claim about human life, but the intervention was Epithalamin, the pineal extract. Synthetic Epitalon is a chemically distinct tetrapeptide. The phrase “epithalamin hormone” can obscure that distinction: Epithalamin is a peptide mixture, and melatonin is the pineal hormone discussed in the cell experiment. I cannot transfer a mortality association from that mixture to AEDG, or assign causation from this study design.

Oocytes and proposed epigenetic effects

A mouse-oocyte experiment found that Epitalon reduced reactive oxygen species and improved mitochondrial activity during post-ovulatory aging in vitro. The reported observations were at 6, 12, and 24 hours. These are findings about isolated mouse egg cells; a human fertility benefit remains untested by this experiment.

The 2025 review also discusses possible binding to histone H1 subtypes and DNA motifs, with changes in how tightly DNA is packaged. The authors describe limited physicochemical and structural characterization and uncertainty about whether the proposed mechanisms are exhaustive. I rank a fuller account of the molecule's behavior above another expansive list of possible applications.

Epitalon safety and regulatory status

Epitalon has no FDA, EMA or MHRA drug approval. A compounded prescription requires a licensed provider's decision, and compounded medicines are not FDA-approved. On FDA's page current as of April 22, 2026, epitalon appears among substances whose nominations were withdrawn. The listed safety concerns remain; withdrawal confers neither drug approval nor Category 1 placement.

The safety concerns discussed in the Epitalon review include the narrow human evidence base and incomplete characterization. Published human pharmacokinetics are missing: the commonly repeated short half-life is an inference from peptide chemistry. Long-term human safety remains poorly characterized. The cancer-cell telomere findings add a mechanistic reason for caution, without establishing a clinical cancer outcome in either direction.

The existing regulatory account also notes that Epitalon was not specifically named on WADA's list as of the 2025 review; classifications can change. For the differences among compounds, the comparison page includes NMN, NAD+ and the acetylated-Epitalon question. Sleep anecdotes and reported side effects are collected in the questions.